Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Spencer, A. U.
Right arrow Articles by Teitelbaum, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, A. U.
Right arrow Articles by Teitelbaum, D. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Premier Research

Parenteral Nutrition–Associated Cholestasis in Neonates: Multivariate Analysis of the Potential Protective Effect of Taurine

Ariel U. Spencer, MD*, Sunkyung Yu, MS{ddagger}, Thomas F. Tracy, MD§, Moustafa M. Aouthmany, MD||, Adolfo Llanos, MD, Morton B. Brown, PhD{ddagger}, Marilyn Brown, MD, Robert J. Shulman, MD#, Ronald B. Hirschl, MD*, Patricia A. DeRusso, MD**, Jean Cox, MS**, Jacqueline Dahlgren, MS*, Peter J. Strouse, MD{dagger}, Jonathan I. Groner, MD{dagger}{dagger} and Daniel H. Teitelbaum, MD*

From the Departments of * Surgery and{dagger} Radiology and the{ddagger} School of Public Health, University of Michigan, and the C.S. Mott Children's Hospital, Ann Arbor, Michigan;§ Brown University, Providence, Rhode Island;|| St. Vincent's Mercy Children's Hospital, Toledo, Ohio; Strong Memorial Hospital, University of Rochester, Rochester, New York; # Baylor College of Medicine, Houston, Texas; ** The Johns Hopkins University School of Medicine, Baltimore, Maryland; and{dagger}{dagger} Columbus Children's Hospital, Columbus, Ohio

Correspondence: Daniel H. Teitelbaum, MD, Section of Pediatric Surgery, University of Michigan Hospitals, F3970 Mott Children's Hospital, Box 0245, Ann Arbor, MI 48109. Electronic mail may be sent to dttlbm{at}umich.edu.

Background: Neonates receiving parenteral nutrition (PN) are at risk for PN-associated cholestasis (PNAC); however, no preventive factors for PNAC have been clearly identified. Despite reports suggesting that taurine may prevent PNAC in neonates, such an effect of taurine has not yet been definitively demonstrated. We determined whether taurine supplementation reduces the incidence of PNAC in premature or critically ill neonates. Methods: This study was part of a prospective, randomized, multi-institutional trial designed to assess cholecystokinin vs placebo as a potential preventive therapy of PNAC. Taurine supplementation of PN varied between institutions. The presence or absence of taurine in PN was analyzed by multivariate analysis, with a primary outcome measure of serum conjugated bilirubin (CB) as a measure of PNAC. Results: Taurine reduced PNAC in premature infants (estimated maximum CB [95% confidence interval] 0.50 mg/dL [–0.17 to 1.18] for those receiving taurine, vs 3.45 mg/dL [1.79–5.11] for neonates not receiving taurine, approaching significance, p = .07). Taurine significantly reduced PNAC in infants with necrotizing enterocolitis (NEC; estimated maximum CB 4.04 mg/dL [2.85–5.23], NEC infants receiving taurine, vs 8.29 mg/dL [5.61–10.96], NEC infants not receiving taurine, p < .01). There were too few neonates with surgical anomalies to evaluate the effect of taurine in this group. Conclusions: Within specific subgroups of neonatal patients, taurine supplementation does offer a very significant degree of protection against PNAC. Patients with NEC or severe prematurity are most likely to benefit substantially from taurine supplementation.


 

Discussant


 

Author's Response

Journal of Parenteral and Enteral Nutrition, Vol. 29, No. 5, 337-344 (2005)
DOI: 10.1177/0148607105029005337


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeoReviewsHome page
F. Navarro, W. A. Gleason, J. M. Rhoads, and R. E. Quiros-Tejeira
Short Bowel Syndrome: Complications, Treatment, and Remaining Questions
NeoReviews, July 1, 2009; 10(7): e339 - e350.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
V. J. Kumpf
Parenteral Nutrition-Associated Liver Disease in Adult and Pediatric Patients
Nutr Clin Pract, June 1, 2006; 21(3): 279 - 290.
[Abstract] [Full Text] [PDF]